Insider Transactions in Q1 2022 at Pacific Biosciences Of California, Inc. (PACB)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 17
2022
|
William W. Ericson Director |
BUY
Other acquisition or disposition
|
Direct |
1,268
+48.69%
|
-
|
|
Mar 17
2022
|
William W. Ericson Director |
SELL
Other acquisition or disposition
|
Indirect |
4,848,397
-100.0%
|
-
|
|
Mar 02
2022
|
Christian O Henry Officer |
BUY
Grant, award, or other acquisition
|
Direct |
107,500
+12.11%
|
-
|
|
Mar 02
2022
|
Mark Van Oene Officer |
BUY
Grant, award, or other acquisition
|
Direct |
72,500
+16.53%
|
-
|
|
Mar 02
2022
|
Peter Fromen Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+20.81%
|
-
|
|
Mar 02
2022
|
Susan G. Kim Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+18.61%
|
-
|
|
Mar 02
2022
|
Michele Farmer Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+26.47%
|
-
|
|
Feb 17
2022
|
Christian O Henry Officer |
SELL
Open market or private sale
|
Direct |
2,122
-0.31%
|
$23,342
$11.09 P/Share
|
|
Feb 17
2022
|
Susan G. Kim Officer |
SELL
Open market or private sale
|
Direct |
1,062
-0.78%
|
$11,682
$11.06 P/Share
|
|
Feb 16
2022
|
Kathy Ordonez Director |
SELL
Open market or private sale
|
Direct |
3,280
-14.99%
|
$36,080
$11.5 P/Share
|
|
Jan 14
2022
|
Marshall Mohr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
$75,000
$3.57 P/Share
|
|
Jan 11
2022
|
Peter Fromen Officer |
SELL
Open market or private sale
|
Direct |
19,720
-12.33%
|
$276,080
$14.3 P/Share
|
|
Jan 11
2022
|
Mark Van Oene Officer |
SELL
Open market or private sale
|
Direct |
41,480
-12.38%
|
$580,720
$14.23 P/Share
|